Summary Atox Bio Inc. (Atox Bio) is a clinical stage biotechnology company that develops immunemodulators against infectious such as necrotizing soft tissue infections and severe intra-abdominal infections. Its lead product, AB103, is developed for the treatment of severe infections in critically ill patients. The company employs technology attenuates multiple pathways which are a common cause of pathology and organ failure in infectious and inflammatory diseases. Atox Bio also conducts pre-clinical research in the areas of organ injury and inflammatory diseases. It focuses its clinical programs on development of treatments for severe infections such as necrotizing soft tissue infections and severe intra-abdominal infections. The company’s investors include OrbiMed, SR One and Lundbeckfond Ventures. Atox Bio is headquartered in Ness Ziona, Israel. Atox Bio Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over... Research Beam Model: Research Beam Product ID: 452475 250 USD New
Atox Bio Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Atox Bio Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Pharmaceuticals
  • Published On : March   2016
  • Pages : 17
  • Publisher : GlobalData
 
 
 
Summary

Atox Bio Inc. (Atox Bio) is a clinical stage biotechnology company that develops immunemodulators against infectious such as necrotizing soft tissue infections and severe intra-abdominal infections. Its lead product, AB103, is developed for the treatment of severe infections in critically ill patients. The company employs technology attenuates multiple pathways which are a common cause of pathology and organ failure in infectious and inflammatory diseases. Atox Bio also conducts pre-clinical research in the areas of organ injury and inflammatory diseases. It focuses its clinical programs on development of treatments for severe infections such as necrotizing soft tissue infections and severe intra-abdominal infections. The company’s investors include OrbiMed, SR One and Lundbeckfond Ventures. Atox Bio is headquartered in Ness Ziona, Israel.

Atox Bio Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Atox Bio Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Atox Bio Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Atox Bio Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Atox Bio Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Atox Bio Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Atox Bio Inc., Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Atox Bio Raises up to USD23 Million in Series E Venture Financing 10
Atox Bio Secures US$3.3 Million In Seed Financing 12
Atox Bio Raises US$2 Million In Venture Financing 13
Atox Bio Inc. - Key Competitors 14
Key Employees 15
Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List Of Tables
List of Tables
Atox Bio Inc., Pharmaceuticals & Healthcare, Key Facts 1
Atox Bio Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Atox Bio Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Atox Bio Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Atox Bio Inc., Deals By Therapy Area, 2010 to YTD 2016 8
Atox Bio Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Atox Bio Raises up to USD23 Million in Series E Venture Financing 10
Atox Bio Secures US$3.3 Million In Seed Financing 12
Atox Bio Raises US$2 Million In Venture Financing 13
Atox Bio Inc., Key Competitors 14
Atox Bio Inc., Key Employees 15
List Of Figures
List of Figures
Atox Bio Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Atox Bio Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Atox Bio Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Atox Bio Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Atox Bio Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Atox Bio Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Atox Bio Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Atox Bio Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter